| Dr James Harold Pavela, MD | |
|
301 University Blvd, Galveston, TX 77555-0570 | |
| (409) 772-7063 | |
| (409) 747-8579 |
| Full Name | Dr James Harold Pavela |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003229147 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R6073 (Texas) | Primary |
| Entity Name | Utmb Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
"What many people say they fear most from an overhaul of the health care system [is] the prospect of the federal government's limiting the medical care they receive," the New York Times reports. Policy experts say people are right to worry about health care costs, but this fear of rationing is unrealistic. "[T]here is nothing in the current proposals in Washington to suggest that the country is likely to embark on a system of medical rationing anytime soon," the Times reports.
EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
Alaska is one of several states suing to overturn the Affordable Care Act - President Obama's health care overhaul. But behind the scenes, state agencies are quietly working on implementing various requirements in the law. One of those requirements is an exchange, which will work kind of like Expedia, but for health insurance plans. While the state studies its options, a bill moving through the legislature would also establish an exchange.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Harold Pavela, MD 301 University Blvd, Galveston, TX 77555-0570 Ph: (409) 772-2653 | Dr James Harold Pavela, MD 301 University Blvd, Galveston, TX 77555-0570 Ph: (409) 772-7063 |
News Archive
"What many people say they fear most from an overhaul of the health care system [is] the prospect of the federal government's limiting the medical care they receive," the New York Times reports. Policy experts say people are right to worry about health care costs, but this fear of rationing is unrealistic. "[T]here is nothing in the current proposals in Washington to suggest that the country is likely to embark on a system of medical rationing anytime soon," the Times reports.
EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
Alaska is one of several states suing to overturn the Affordable Care Act - President Obama's health care overhaul. But behind the scenes, state agencies are quietly working on implementing various requirements in the law. One of those requirements is an exchange, which will work kind of like Expedia, but for health insurance plans. While the state studies its options, a bill moving through the legislature would also establish an exchange.
› Verified 7 days ago
Diaa Hamouda, MBBCH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Jsa 9.128, Galveston, TX 77555 Phone: 409-772-8031 Fax: 409-772-6940 | |
Syed Mustajab Hasan, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Drive, Galveston, TX 77555 Phone: 409-762-2328 Fax: 832-632-7866 | |
Arielle Degueure, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 Fax: 409-747-8579 | |
Dr. Shawn Pua Eiko Nishi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-643-4587 | |
Suyuan Tan, Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 | |
Shahzad Jokhio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-722-2222 |